Cas No.: | 1638970-43-0 |
Chemical Name: | (S)-2-((S)-2-((S)-2-(7-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)heptanamido)propanamido)propanamido)-N1-(4-hydroxyphenyl)-N4-tritylsuccinamide |
Synonyms: | MC-Ala-Ala-Asn(Trt)-PAB; XQN70430; XQN-70430; XQN 70430; |
SMILES: | O=C(C[C@H](NC([C@@H](NC([C@@H](NC(CCCCCCN1C(C=CC1=O)=O)=O)C)=O)C)=O)C(NC2=CC=C(C=C2)O)=O)NC(C3=CC=CC=C3)(C4=CC=CC=C4)C5=CC=CC=C5 |
Formula: | C46H50N6O8 |
M.Wt: | 814.94 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | XQN70430, also known as MC-Ala-Ala-Asn(Trt)-PAB, is a hetero bifunctional cross-linker, useful in antibody drug conjugation (ADC). XQN70430 is a fissionable linker which is specifically activated in a tumor microenvironment. XQN70430 was reported in patent WO 2016026458. This product has no formal name at the moment. |